Arrowhead Pharmaceuticals (ARWR) Capital Expenditures (QoQ) (2012 - 2026)
Arrowhead Pharmaceuticals (ARWR) Capital Expenditures (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arrowhead Pharmaceuticals | 11.98 Bn | 10.18 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.41% |
| Dec 31, 2025 | 3,213.04% |
| Sep 30, 2025 | 99.45% |
| Jun 30, 2025 | -221.76% |
| Mar 31, 2025 | 297.79% |
| Dec 31, 2024 | -89.40% |
| Sep 30, 2024 | 68.10% |
| Jun 30, 2024 | -57.60% |
| Mar 31, 2024 | -50.37% |
| Dec 31, 2023 | -57.39% |
| Sep 30, 2023 | 418.40% |
| Jun 30, 2023 | -285.26% |
| Mar 31, 2023 | -29.80% |
| Dec 31, 2022 | 18.95% |
| Sep 30, 2022 | 243.03% |
| Jun 30, 2022 | 100.67% |
| Mar 31, 2022 | -17.76% |
| Dec 31, 2021 | -29.53% |
| Sep 30, 2021 | 108.57% |
| Jun 30, 2021 | -45.14% |